The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: plasma metabolomics analysis
Open accessAbstract
Background: Polycystic ovary syndrome (PCOS) is a heterogeneous endocrine disorder accompanied with an increased risk of developing type 2 diabetes mellitus and cardiovascular disease; despite being a common condition, the pathogenesis of PCOS remains unclear. Our aim was to investigate the potential metabolic profiles for different phenotypes of PCOS, as well as for the early prognosis of complications. Methods: A total of 217 women with PCOS and 48 healthy women as normal controls were studied. Plasma samples of subjects were tested using two different analytical platforms of metabolomics: 1 H nuclear magnetic resonance (NMR) and gas chromatography/time-of-flight mass spectrometry (GC/TOF-MS). Results: Our results showed that carbohydrate, lipid and amino acid metabolisms were influenced in PCOS. The levels of lactate, long-chain fatty acids, triglyceride and very low-density lipoprotein were elevated, while glucose, phosphatidylcholine and high-density lipoprotein (HDL) concentrations were reduced in PCOS patients as compared with controls. Additionally, the levels of alanine, valine, serine, threonine, ornithine, phenylalanine, tyrosine and tryptophan were generally increased, whereas the levels of glycine and proline were significantly reduced in PCOS samples compared to controls. Furthermore, the ratio of branched-chain amino acid to aromatic amino acid concentrations (BCAA/AAA) in PCOS plasma was significantly reduced in PCOS patients and was insusceptible to obesity and insulin sensitivity. Conclusions: Our results suggested that the enhanced glycolysis and inhibited tricarboxylic acid cycle (TAC) in women with PCOS. Decrease of BCAA/AAA ratio was directly correlated with the development of PCOS. Ovulatory dysfunction of PCOS patients was associated with raised production of serine, threonine, phenylalanine, tyrosine and ornithine. Elevated levels of valine and leucine, and decreased concentrations of glycine in PCOS plasma could contribute to insulin sensitivity and could be considered as the potential biomarkers for long-term risk assessment of diabetes mellitus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Newgard, C. B., An, J., Bain, J. R., Muehlbauer, M. J., Stevens, R. D., Lien, L. F., Haqq, A. M., Shah, S. H., Arlotto, M., Slentz, C. A., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.02.002 · Cited by 3,165
Franks, S. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509283331307 · Cited by 2,463
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
Goodarzi, M. O., Dumesic, D. A., Chazenbalk, G., & Azziz, R. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.217 · Cited by 1,488
Norman, R. J., Dewailly, D., Legro, R. S., & Hickey, T. E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61345-2 · Cited by 1,360
Lipid Levels in Polycystic Ovary Syndrome: Systematic Review and Meta-Analysis
Wild, R. A., Rizzo, M., Clifton, S., & Carmina, E. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.12.027 · Cited by 477
Polycystic ovarian syndrome: Pathophysiology, molecular aspects and clinical implications
Diamanti-Kandarakis, E. (2008) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399408000598 · Cited by 294
Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis
Toulis, K. A., Goulis, D. G., Farmakiotis, D., Georgopoulos, N. A., Katsikis, I., Tarlatzis, B. C., Papadimas, I., & Panidis, D. (2009) · Human Reproduction Update · doi:10.1093/humupd/dmp006 · Cited by 262 · cited 1×
“Adiponectin levels seem to be lower in women with PCOS compared with non-PCOS controls after controlling for BMI-related effects [28].”
BackgroundClinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes
Guastella, E., Longo, R. A., & Carmina, E. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.02.014 · Cited by 205
Panidis, D., Tziomalos, K., Misichronis, G., Papadakis, E., Betsas, G., Katsikis, I., & Macut, D. (2012) · Human Reproduction · doi:10.1093/humrep/der418 · Cited by 155
Research works printed but not linked: 28
- Rizzo M, Berneis K, Spinas G, Rini GB, Carmina E: Long-term consequences of polycystic ovary syndrome on cardiovascular risk. Fertil Steril. 2009, 91: 1563-1567. 10.1016/j.fertnstert.2008.09.070. · DOI
- Moran LJ, Misso ML, Wild RA, Norman RJ: Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2010, 16: 347-363. 10.1093/humupd/dmq001. · DOI · Paper page
- Hughes C, Elgasim M, Layfield R, Atiomo W: Genomic and post-genomic approaches to polycystic ovary syndrome--progress so far: Mini Review. Hum Reprod. 2006, 21: 2766-2775. 10.1093/humrep/del222. · DOI
- Diamanti-Kandarakis E, Piperi C, Spina J, Argyrakopoulou G, Papanastasiou L, Bergiele A, Panidis D: Polycystic ovary syndrome: the influence of environmental and genetic factors. Hormones (Athens). 2006, 5: 17-34. · DOI
- Mukherjee S, Maitra A: Molecular & genetic factors contributing to insulin resistance in polycystic ovary syndrome. Indian J Med Res. 2010, 131: 743-760.
- Giallauria F, Orio F, Palomba S, Lombardi G, Colao A, Vigorito C: Cardiovascular risk in women with polycystic ovary syndrome. J Cardiovasc Med (Hagerstown). 2008, 9: 987-992. 10.2459/JCM.0b013e32830b58d4. · DOI
- Wang ET, Calderon-Margalit R, Cedars MI, Daviglus ML, Merkin SS, Schreiner PJ, Sternfeld B, Wellons M, Schwartz SM, Lewis CE, Williams OD, Siscovick DS, Bibbins-Domingo K: Polycystic ovary syndrome and risk for long-term diabetes and dyslipidemia. Obstet Gynecol. 2011, 117: 6-13. 10.1097/AOG.0b013e31820209bb. · DOI · Paper page
- Franks S: Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria. J Clin Endocrinol Metab. 2006, 91: 786-789. · DOI · Paper page
- Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004, 81: 19-25.
- Wishart DS: Metabolomics: the principles and potential applications to transplantation. Am J Transplant. 2005, 5: 2814-2820. 10.1111/j.1600-6143.2005.01119.x. · DOI · Paper page
- Lenz EM, Wilson ID: Analytical strategies in metabonomics. J Proteome Res. 2007, 6: 443-458. 10.1021/pr0605217. · DOI · Paper page
- Wu Q, Zhang Q, Sun B, Yan X, Tang Y, Qiao X, Chen Q, Yu S, Liang F: 1H NMR-based metabonomic study on the metabolic changes in the plasma of patients with functional dyspepsia and the effect of acupuncture. J Pharm Biomed Anal. 2010, 51: 698-704. 10.1016/j.jpba.2009.09.042. · doi:10.1016/j.jpba.2009.09.042
- Feng B, Wu S, Lv S, Liu F, Chen H, Yan X, Li Y, Dong F, Wei L: Metabolic profiling analysis of a d-galactosamine/lipopolysaccharide-induced mouse model of fulminant hepatic failure. J Proteome Res. 2007, 6: 2161-2167. 10.1021/pr0606326. · DOI
- Yang Y, Qiao J, Li R, Li MZ: Is interleukin-18 associated with polycystic ovary syndrome?. Reprod Biol Endocrinol. 2011, 9: 7-10.1186/1477-7827-9-7. · DOI
- Sun L, Hu W, Liu Q, Hao Q, Mao S, Sun B, Zhang Q, Qiao J, Yan X: Metabonomics reveals plasma metabolic changes and inflammatory marker in polycystic ovary syndrome patients. J Proteome Res. 2012, 11: 2937-2946. 10.1021/pr3000317. · DOI
- Pirwany IR, Fleming R, Greer IA, Packard CJ, Sattar N: Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters. Clin Endocrinol (Oxf). 2001, 54: 447-453. 10.1046/j.1365-2265.2001.01228.x. · DOI · Paper page
- Marei WF, Wathes DC, Fouladi-Nashta AA: Impact of linoleic acid on bovine oocyte maturation and embryo development. Reproduction. 2010, 139: 979-988. 10.1530/REP-09-0503. · DOI · Paper page
- Toborek M, Lee YW, Garrido R, Kaiser S, Hennig B: Unsaturated fatty acids selectively induce an inflammatory environment in human endothelial cells. Am J Clin Nutr. 2002, 75: 119-125. · DOI · Paper page
- Wang TJ, Larson MG, Vasan RS, Cheng S, Rhee EP, McCabe E, Lewis GD, Fox CS, Jacques PF, Fernandez C, O'Donnell CJ, Carr SA, Mootha VK, Flore JC, Souza A, Melander O, Clish CB, Gerszten RE: Metabolite profiles and the risk of developing diabetes. Nat Med. 2011, 17: 448-453. 10.1038/nm.2307. · DOI · Paper page
- Wurtz P, Tiainen M, Makinen VP, Kangas AJ, Soininen P, Saltevo J, Keinanen-Kiukaanniemi S, Mantyselka P, Lehtimaki T, Laakso M, Jula A, Kahonen M, Vanhala M, Ala-Korpela M: Circulating metabolite predictors of glycemia in middle-aged men and women. Diabetes Care. 2012, 35: 1749-1756. 10.2337/dc11-1838. · DOI · Paper page
- Garcia-Macedo R, Sanchez-Munoz F, Almanza-Perez JC, Duran-Reyes G, Alarcon-Aguilar F, Cruz M: Glycine increases mRNA adiponectin and diminishes pro-inflammatory adipokines expression in 3T3-L1 cells. Eur J Pharmacol. 2008, 587: 317-321. 10.1016/j.ejphar.2008.03.051. · DOI
- Li F, Yin Y, Tan B, Kong X, Wu G: Leucine nutrition in animals and humans: mTOR signaling and beyond. Amino Acids. 2011, 41: 1185-1193. 10.1007/s00726-011-0983-2. · DOI · Paper page
- Macotela Y, Emanuelli B, Bang AM, Espinoza DO, Boucher J, Beebe K, Gall W, Kahn CR: Dietary leucine--an environmental modifier of insulin resistance acting on multiple levels of metabolism. PLoS One. 2011, 6: e21187-10.1371/journal.pone.0021187. · DOI · Paper page
- Chand AL, Legge M: Amino acid transport system L activity in developing mouse ovarian follicles. Hum Reprod. 2011, 26: 3102-3108. 10.1093/humrep/der298. · DOI
- Carmina E, Guastella E, Longo RA, Rini GB, Lobo RA: Correlates of increased lean muscle mass in women with polycystic ovary syndrome. Eur J Endocrinol. 2009, 161: 583-589. 10.1530/EJE-09-0398. · DOI
- Escobar-Morreale HF, Samino S, Insenser M, Vinaixa M, Luque-Ramirez M, Lasuncion MA, Correig X: Metabolic heterogeneity in polycystic ovary syndrome is determined by obesity: plasma metabolomic approach using GC-MS. Clin Chem. 2012, 58: 999-1009. 10.1373/clinchem.2011.176396. · DOI
- Chen MJ, Chiu HM, Chen CL, Yang WS, Yang YS, Ho HN: Hyperandrogenemia is independently associated with elevated alanine aminotransferase activity in young women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2010, 95: 3332-3341. 10.1210/jc.2009-2698. · DOI
- Diao FY, Xu M, Hu Y, Li J, Xu Z, Lin M, Wang L, Zhou Y, Zhou Z, Liu J, Sha J: The molecular characteristics of polycystic ovary syndrome (PCOS) ovary defined by human ovary cDNA microarray. J Mol Endocrinol. 2004, 33: 59-72. 10.1677/jme.0.0330059. · DOI
Cited by
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
Cossarizza, A., Chang, H., Radbruch, A., Acs, A., Adam, D., Adam‐Klages, S., Agace, W. W., Aghaeepour, N., Akdis, M., Allez, M., et al. (2019) · European Journal of Immunology · doi:10.1002/eji.201970107 · Cited by 979
Self-citationOocyte competence in women with polycystic ovary syndrome
Palomba, S., Daolio, J., & La Sala, G. B. (2017) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2016.11.008 · Cited by 294
He, F.-F., & Li, Y.-M. (2020) · Journal of Ovarian Research · doi:10.1186/s13048-020-00670-3 · Cited by 289
Metabolic Syndrome and PCOS: Pathogenesis and the Role of Metabolites
Chen, W., & Pang, Y. (2021) · Metabolites · doi:10.3390/metabo11120869 · Cited by 228
Menstrual cycle rhythmicity: metabolic patterns in healthy women
Draper, C. F., Duisters, K., Weger, B., Chakrabarti, A., Harms, A. C., Brennan, L., Hankemeier, T., Goulet, L., Konz, T., Martin, F. P., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-32647-0 · Cited by 221
Metadata
- Authors
- Zhao, Y., Fu, L., Li, R., Wang, L.-N., Yang, Y., Liu, N.-N., Zhang, C.-M., Wang, Y., Liu, P., Tu, B.-B., Zhang, X., & Qiao, J.
- Venue
- BMC Medicine
- Published
- 2012-11-30
- Volume
- 10
- Issue
- 1
- Pages
- 153-153
- ISSN
- 1741-7015 (ISSN-L)
- OpenAlex
- W1974198965
- Cited by
- 225
- References
- 9
- FWCI
- 9.48
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: plasma metabolomics analysis. https://app.cochat.ai/papers/10.1186/1741-7015-10-153
- The paper
- Zhao, Y., Fu, L., Li, R., Wang, L.-N., Yang, Y., Liu, N.-N., Zhang, C.-M., Wang, Y., Liu, P., Tu, B.-B., Zhang, X., & Qiao, J. (2012). Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: plasma metabolomics analysis. BMC Medicine. https://doi.org/10.1186/1741-7015-10-153
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.